Humacyte (HUMA) reported second-quarter 2026 revenue of $0.4 million, up from $0.3 million a year earlier, and a net loss of $36.8 million, compared with a net loss of $37.7 million in the second quarter of 2025.
The company said Symvess commercial sales were $0.4 million in the quarter, compared with $0.1 million a year earlier. Humacyte also reported Phase 3 dialysis access results for ATEV, plans to file a supplemental BLA in the second half of 2026, and said the FDA accepted its IND for a first-in-human CTEV study in CABG.
- Second-quarter 2026 total revenue was $406,000.
- Net loss was $36.8 million, or $0.16 per basic and diluted share.
- Six-month 2026 revenue was $0.9 million, compared with $0.8 million a year earlier.
- Cash, cash equivalents and restricted cash totaled $80.3 million as of June 30, 2026.
- Humacyte raised $57.5 million in gross proceeds from a June 2026 public offering.
- The company estimated 2026 net savings of about $14.3 million from workforce and operating cost reductions.
$HUMAW Hedge Fund Activity
We have seen 2 institutional investors add shares of $HUMAW stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 30,859 shares (-40.9%) from their portfolio in Q1 2026, for an estimated $2,820
- LPL FINANCIAL LLC removed 25,000 shares (-9.6%) from their portfolio in Q2 2026, for an estimated $239
- WOLVERINE ASSET MANAGEMENT LLC added 10,454 shares (+27.5%) to their portfolio in Q2 2026, for an estimated $100
- TWO SIGMA SECURITIES, LLC removed 3,218 shares (-7.1%) from their portfolio in Q1 2026, for an estimated $294
- UBS GROUP AG removed 894 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $81
- JANE STREET GROUP, LLC added 200 shares (+0.4%) to their portfolio in Q1 2026, for an estimated $18
- SIO CAPITAL MANAGEMENT, LLC added 0 shares (+0.0%) to their portfolio in Q1 2026, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.